Switzerland-based pharmaceutical company Roche will invest $50 billion in the United States over a five-year period, setting up new facilities and expanding existing ones, the company said in an April 22 statement.
The investments “are expected to create more than 12,000 new jobs, including nearly 6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities.”
As part of the investments, a gene therapy-manufacturing facility will be opened in Pennsylvania, a new manufacturing facility in Indiana for continuous glucose monitoring, and a 900,000 square-foot manufacturing facility to support the company’s weight-loss medicine portfolio.
A new research and development (R&D) center in Massachusetts is also being planned, which aims to conduct “cutting-edge artificial intelligence (AI) research” and serve as a “hub for our new cardiovascular, renal, and metabolism research and development efforts,” said Roche….